Over 100 patients signed up for the chance to participate in the clinical trials at Duke (2007-10) that promised a custom-tailored cancer treatment spewed out by a cutting-edge prediction model developed by Anil Potti, Joseph Nevins and their team at Duke. Their model purported to predict your probable response to one or another chemotherapy based on microarray analyses of various tumors. While they are now described as “false pioneers” of personalized cancer treatments, it’s not clear what has been learned from the fireworks surrounding the Potti episode overall. Most of the popular focus has been on glaring typographical and data processing errors—at least that’s what I mainly heard about until recently. Although they were quite crucial to the science in this case,(surely more so than Potti’s CV padding) what interests me now are the general methodological and logical concerns that rarely make it into the popular press. Continue reading
Blog Table of Contents: March and April 2014
BLOG Contents: March and April 2014
Compiled by Jean Miller and Nicole Jinn
March 2014
(3/1) Cosma Shalizi gets tenure (at last!) (metastat announcement)
(3/2) Significance tests and frequentist principles of evidence: Phil6334 Day #6
(3/3) Capitalizing on Chance (ii)
(3/4) Power, power everywhere–(it) may not be what you think! [illustration]
(3/8) Msc kvetch: You are fully dressed (even under you clothes)? Continue reading